Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert 
CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift 
Honduras Awaits Final Election Results as Asfura Holds Slim Lead Amid U.S. Attention 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Australia Progresses AUKUS Review as U.S. Affirms Strong Support 
China’s Expanding Maritime Military Presence Alarms Taiwan and Japan 
Zelenskiy Describes “Substantive” Call With Trump Envoys as Ukraine, U.S. Explore Peace Path 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
U.S. Expected to Expand Travel Ban to More Than 30 Countries 
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Cuba Quietly Signals Openness to Post-Maduro Venezuela as U.S. Pressure Intensifies 
Australia Imposes Sanctions on Taliban Officials Over Human Rights Abuses 
U.S. Defense Secretary Hegseth Defends Second Strike on Suspected Drug Boat Amid War-Crime Concerns 
The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.
